Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL13RA2 anticorps

IL13RA2 Reactivité: Humain ELISA, IHC, FACS Hôte: Souris Monoclonal B-D13 unconjugated
N° du produit ABIN1383686
  • Antigène Voir toutes IL13RA2 Anticorps
    IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
    Reactivité
    • 55
    • 27
    • 11
    • 7
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 45
    • 8
    • 3
    Souris
    Clonalité
    • 50
    • 6
    Monoclonal
    Conjugué
    • 27
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp IL13RA2 est non-conjugé
    Application
    • 48
    • 25
    • 15
    • 9
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
    Specificité
    Recognises the IL-13 receptor a2 (IL-13 Ra2), a 44 kDa protein
    Purification
    Ion exchange chromatography
    Stérilité
    0.22 μm filtered
    Immunogène
    IL-13Ra2 transfected CHO cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
    Clone
    B-D13
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product IL13RA2 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
    Agent conservateur
    Without preservative
    Stock
    4 °C
    Stockage commentaire
    Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
  • Kawakami, Terabe, Kioi, Berzofsky, Puri: "Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 15, pp. 4678-86, (2006) (PubMed).

    Kawakami, Kawakami, Puri: "Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease." dans: Molecular cancer therapeutics, Vol. 3, Issue 2, pp. 137-47, (2004) (PubMed).

    Blanchard, Durual, Estienne, Bouzakri, Heim, Blin, Cuber: "IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 6, pp. 3775-83, (2004) (PubMed).

    Kawakami, Kawakami, Kasperbauer, Hinkley, Tsukuda, Strome, Puri: "Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 9, Issue 17, pp. 6381-8, (2003) (PubMed).

    Joshi, Kawakami, Leland, Puri: "Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 8, Issue 6, pp. 1948-56, (2002) (PubMed).

    Lordan, Bucchieri, Richter, Konstantinidis, Holloway, Thornber, Puddicombe, Buchanan, Wilson, Djukanović, Holgate, Davies: "Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 1, pp. 407-14, (2002) (PubMed).

    Kawakami, Kawakami, Puri: "IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 12, pp. 7119-26, (2002) (PubMed).

    Joshi, Plautz, Puri: "Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas." dans: Cancer research, Vol. 60, Issue 5, pp. 1168-72, (2000) (PubMed).

  • Antigène
    IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
    Autre désignation
    CD213a2 (IL13RA2 Produits)
    Synonymes
    anticorps il-13ra2, anticorps sb:cb602, anticorps si:dkeyp-110c7.6, anticorps CD213A2, anticorps CT19, anticorps IL-13R, anticorps IL13BP, anticorps CD213a2, anticorps IL-13R-alpha-2, anticorps IL13RA2, anticorps interleukin 13 receptor, alpha 2, anticorps interleukin 13 receptor subunit alpha 2, anticorps interleukin 13 receptor subunit alpha 2 S homeolog, anticorps il13ra2, anticorps IL13RA2, anticorps il13ra2.S, anticorps Il13ra2
    Sujet
    IL-13Ra2
    Poids moléculaire
    74 kDa
Vous êtes ici:
Support technique